Nvidia Cut to $240 By Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes-To The Moon - Tiger Brokers Online Investing Community

121
6
Favorite

Nvidia Cut to $240 By Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes

Benzinga2022-08-09

Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

121

Report

Comment（6）

mickt
·2022-08-09
Buy
Reply
Like
Report
NPC69
·2022-08-09
K
Reply
1
Report
nsk
·2022-08-09
Ok
Reply
Like
Report
Khoo12
·2022-08-09
Hmmm
Reply
1
Report
Bodoh
·2022-08-09
Ooops
Reply
1
Report
Huat1333
·2022-08-09
Haha....u down i up [Miser] [Miser]
Reply
1
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1164052302?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-09 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164052302","market":"us","top_or_hot":-1,"title":"Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes","media":"Benzinga","content":"<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-09 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BC","symbol_name":"宾士域","start_time":0,"source_url":"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday","article_id":"1164052302","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164052302","pubTimestamp":1660042942,"columns":[],"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Me","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BC":"宾士域","TNDM":"糖尿病保健","MNDY":"Monday.com Ltd.","CRSP":"CRISPR Therapeutics AG","ACAD":"阿卡迪亚","NVDA":"英伟达"},"translate_title":"雷蒙德·詹姆斯将英伟达降至240美元；Piper Sandler价格目标的变化推动Monday.com升至180美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACAD":0.9,"BC":0.9,"CRSP":0.9,"MNDY":0.9,"NVDA":0.9,"TNDM":0.9},"content_text":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.Piper Sandler boosted monday.com Ltd. price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.Wells Fargo cut Tandem Diabetes Care, Inc. price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.BMO Capital raised Brunswick Corporation price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.Chardan Capital cut CRISPR Therapeutics AG price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9904232101,"gmtCreate":1660051819806,"gmtModify":1703477340108,"author":{"id":"3583898456116036","authorId":"3583898456116036","name":"mickt","avatar":"https://static.tigerbbs.com/b524a9181cc4970fbdddc8aa3ad8b5ec","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3583898456116036","idStr":"3583898456116036"},"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9904232101","repostId":1164052302,"repostType":4,"repost":{"id":"1164052302","kind":"news","pubTimestamp":1660042942,"share":"https://ttm.financial/m/news/1164052302?lang=&edition=fundamental","pubTime":"2022-08-09 19:02","market":"us","language":"en","title":"Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164052302","media":"Benzinga","summary":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Me","content":"<html><head></head><body><ul><li>Raymond James cut the price target on <b>NVIDIA Corporation</b> from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.</li><li>Piper Sandler boosted <b>monday.com Ltd.</b> price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.</li><li>Wells Fargo cut <b>Tandem Diabetes Care, Inc.</b> price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.</li><li>BMO Capital raised <b>Brunswick Corporation</b> price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.</li><li>HC Wainwright &amp; Co. raised <b>ACADIA Pharmaceuticals Inc.</b> price target from $20 to $25. However, HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.</li><li>Chardan Capital cut <b>CRISPR Therapeutics AG</b> price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-09 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRSP":"CRISPR Therapeutics AG","BC":"宾士域","MNDY":"Monday.com Ltd.","NVDA":"英伟达","ACAD":"阿卡迪亚","TNDM":"糖尿病保健"},"source_url":"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164052302","content_text":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.Piper Sandler boosted monday.com Ltd. price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.Wells Fargo cut Tandem Diabetes Care, Inc. price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.BMO Capital raised Brunswick Corporation price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.Chardan Capital cut CRISPR Therapeutics AG price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9904233290,"gmtCreate":1660051138112,"gmtModify":1703477333999,"author":{"id":"3584779133668268","authorId":"3584779133668268","name":"NPC69","avatar":"https://static.tigerbbs.com/47e7ac55312ae8dd1c9e7cb92adad089","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3584779133668268","idStr":"3584779133668268"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9904233290","repostId":1164052302,"repostType":4,"repost":{"id":"1164052302","kind":"news","pubTimestamp":1660042942,"share":"https://ttm.financial/m/news/1164052302?lang=&edition=fundamental","pubTime":"2022-08-09 19:02","market":"us","language":"en","title":"Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164052302","media":"Benzinga","summary":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Me","content":"<html><head></head><body><ul><li>Raymond James cut the price target on <b>NVIDIA Corporation</b> from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.</li><li>Piper Sandler boosted <b>monday.com Ltd.</b> price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.</li><li>Wells Fargo cut <b>Tandem Diabetes Care, Inc.</b> price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.</li><li>BMO Capital raised <b>Brunswick Corporation</b> price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.</li><li>HC Wainwright &amp; Co. raised <b>ACADIA Pharmaceuticals Inc.</b> price target from $20 to $25. However, HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.</li><li>Chardan Capital cut <b>CRISPR Therapeutics AG</b> price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-09 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRSP":"CRISPR Therapeutics AG","BC":"宾士域","MNDY":"Monday.com Ltd.","NVDA":"英伟达","ACAD":"阿卡迪亚","TNDM":"糖尿病保健"},"source_url":"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164052302","content_text":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.Piper Sandler boosted monday.com Ltd. price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.Wells Fargo cut Tandem Diabetes Care, Inc. price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.BMO Capital raised Brunswick Corporation price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.Chardan Capital cut CRISPR Therapeutics AG price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9904298802,"gmtCreate":1660049578808,"gmtModify":1703477320570,"author":{"id":"3566130979400930","authorId":"3566130979400930","name":"nsk","avatar":"https://static.tigerbbs.com/ca5161a1cfd9f69617bbe604d09aa849","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3566130979400930","idStr":"3566130979400930"},"htmlText":"Ok&nbsp;","listText":"Ok&nbsp;","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9904298802","repostId":1164052302,"repostType":4,"repost":{"id":"1164052302","kind":"news","pubTimestamp":1660042942,"share":"https://ttm.financial/m/news/1164052302?lang=&edition=fundamental","pubTime":"2022-08-09 19:02","market":"us","language":"en","title":"Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164052302","media":"Benzinga","summary":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Me","content":"<html><head></head><body><ul><li>Raymond James cut the price target on <b>NVIDIA Corporation</b> from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.</li><li>Piper Sandler boosted <b>monday.com Ltd.</b> price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.</li><li>Wells Fargo cut <b>Tandem Diabetes Care, Inc.</b> price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.</li><li>BMO Capital raised <b>Brunswick Corporation</b> price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.</li><li>HC Wainwright &amp; Co. raised <b>ACADIA Pharmaceuticals Inc.</b> price target from $20 to $25. However, HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.</li><li>Chardan Capital cut <b>CRISPR Therapeutics AG</b> price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-09 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRSP":"CRISPR Therapeutics AG","BC":"宾士域","MNDY":"Monday.com Ltd.","NVDA":"英伟达","ACAD":"阿卡迪亚","TNDM":"糖尿病保健"},"source_url":"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164052302","content_text":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.Piper Sandler boosted monday.com Ltd. price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.Wells Fargo cut Tandem Diabetes Care, Inc. price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.BMO Capital raised Brunswick Corporation price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.Chardan Capital cut CRISPR Therapeutics AG price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9904207159,"gmtCreate":1660048951873,"gmtModify":1703477312232,"author":{"id":"3564738902623228","authorId":"3564738902623228","name":"Khoo12","avatar":"https://static.tigerbbs.com/a1637796379aeed1538616117eb09330","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3564738902623228","idStr":"3564738902623228"},"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9904207159","repostId":1164052302,"repostType":4,"repost":{"id":"1164052302","kind":"news","pubTimestamp":1660042942,"share":"https://ttm.financial/m/news/1164052302?lang=&edition=fundamental","pubTime":"2022-08-09 19:02","market":"us","language":"en","title":"Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164052302","media":"Benzinga","summary":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Me","content":"<html><head></head><body><ul><li>Raymond James cut the price target on <b>NVIDIA Corporation</b> from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.</li><li>Piper Sandler boosted <b>monday.com Ltd.</b> price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.</li><li>Wells Fargo cut <b>Tandem Diabetes Care, Inc.</b> price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.</li><li>BMO Capital raised <b>Brunswick Corporation</b> price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.</li><li>HC Wainwright &amp; Co. raised <b>ACADIA Pharmaceuticals Inc.</b> price target from $20 to $25. However, HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.</li><li>Chardan Capital cut <b>CRISPR Therapeutics AG</b> price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-09 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRSP":"CRISPR Therapeutics AG","BC":"宾士域","MNDY":"Monday.com Ltd.","NVDA":"英伟达","ACAD":"阿卡迪亚","TNDM":"糖尿病保健"},"source_url":"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164052302","content_text":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.Piper Sandler boosted monday.com Ltd. price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.Wells Fargo cut Tandem Diabetes Care, Inc. price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.BMO Capital raised Brunswick Corporation price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.Chardan Capital cut CRISPR Therapeutics AG price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9904676863,"gmtCreate":1660046503154,"gmtModify":1703477289245,"author":{"id":"3559859558754319","authorId":"3559859558754319","name":"Bodoh","avatar":"https://static.tigerbbs.com/349218ea2852130ca86ce660b4aa2d59","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3559859558754319","idStr":"3559859558754319"},"htmlText":"Ooops","listText":"Ooops","text":"Ooops","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9904676863","repostId":1164052302,"repostType":4,"repost":{"id":"1164052302","kind":"news","pubTimestamp":1660042942,"share":"https://ttm.financial/m/news/1164052302?lang=&edition=fundamental","pubTime":"2022-08-09 19:02","market":"us","language":"en","title":"Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164052302","media":"Benzinga","summary":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Me","content":"<html><head></head><body><ul><li>Raymond James cut the price target on <b>NVIDIA Corporation</b> from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.</li><li>Piper Sandler boosted <b>monday.com Ltd.</b> price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.</li><li>Wells Fargo cut <b>Tandem Diabetes Care, Inc.</b> price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.</li><li>BMO Capital raised <b>Brunswick Corporation</b> price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.</li><li>HC Wainwright &amp; Co. raised <b>ACADIA Pharmaceuticals Inc.</b> price target from $20 to $25. However, HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.</li><li>Chardan Capital cut <b>CRISPR Therapeutics AG</b> price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-09 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRSP":"CRISPR Therapeutics AG","BC":"宾士域","MNDY":"Monday.com Ltd.","NVDA":"英伟达","ACAD":"阿卡迪亚","TNDM":"糖尿病保健"},"source_url":"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164052302","content_text":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.Piper Sandler boosted monday.com Ltd. price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.Wells Fargo cut Tandem Diabetes Care, Inc. price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.BMO Capital raised Brunswick Corporation price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.Chardan Capital cut CRISPR Therapeutics AG price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9904646707,"gmtCreate":1660044255511,"gmtModify":1703477273689,"author":{"id":"3559014783889591","authorId":"3559014783889591","name":"Huat1333","avatar":"https://community-static.tradeup.com/news/a4c138e1ce20043d7996468a91a225ac","vip":1,"hat":"https://static.tigerbbs.com/50a4c8d97279fa9f8f1fa9749a6bdff4","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3559014783889591","idStr":"3559014783889591"},"htmlText":"Haha....u down i up&nbsp;[Miser]&nbsp;[Miser]&nbsp;","listText":"Haha....u down i up&nbsp;[Miser]&nbsp;[Miser]&nbsp;","text":"Haha....u down i up [Miser] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9904646707","repostId":1164052302,"repostType":4,"repost":{"id":"1164052302","kind":"news","pubTimestamp":1660042942,"share":"https://ttm.financial/m/news/1164052302?lang=&edition=fundamental","pubTime":"2022-08-09 19:02","market":"us","language":"en","title":"Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164052302","media":"Benzinga","summary":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Me","content":"<html><head></head><body><ul><li>Raymond James cut the price target on <b>NVIDIA Corporation</b> from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.</li><li>Piper Sandler boosted <b>monday.com Ltd.</b> price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.</li><li>Wells Fargo cut <b>Tandem Diabetes Care, Inc.</b> price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.</li><li>BMO Capital raised <b>Brunswick Corporation</b> price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.</li><li>HC Wainwright &amp; Co. raised <b>ACADIA Pharmaceuticals Inc.</b> price target from $20 to $25. However, HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.</li><li>Chardan Capital cut <b>CRISPR Therapeutics AG</b> price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.</li></ul></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Cut to $240 By  Raymond James; Monday.com Boosted to $180 By Piper Sandler | Price Target Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-09 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRSP":"CRISPR Therapeutics AG","BC":"宾士域","MNDY":"Monday.com Ltd.","NVDA":"英伟达","ACAD":"阿卡迪亚","TNDM":"糖尿病保健"},"source_url":"https://www.benzinga.com/news/22/08/28412963/nvidia-to-240-here-are-5-other-price-target-changes-for-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164052302","content_text":"Raymond James cut the price target on NVIDIA Corporation from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.Piper Sandler boosted monday.com Ltd. price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.Wells Fargo cut Tandem Diabetes Care, Inc. price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.BMO Capital raised Brunswick Corporation price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.Chardan Capital cut CRISPR Therapeutics AG price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":121,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}